Serum

Xiuxia Sun, Yongbao Chen, Jifang Tan, Xuanchang Qi

Open access · greenAbstract read

In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

0.3field-weighted citation impact, top 41% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

Repressing IRS1/2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K/AKT/mTOR pathway and inducing autophagy.The Kaohsiung journal of medical sciences · 2023
Article
Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).International journal of oncology · 2021
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Xiuxia SunDepartment of Otorhinolaryngology, Affiliated Hospital of Weifang Medical College Weifang, Shandong, China.

Yongbao ChenDepartment of Otorhinolaryngology, Yishui Central Hospital of Linyi Shandong, China.

Jifang TanDepartment of Otorhinolaryngology, Air Force Jinan to Recruit Students in Flight Training Jinan, Shandong, China.

Xuanchang QiDepartment of Otorhinolaryngology, Affiliated Hospital of Weifang Medical College Weifang, Shandong, China.

Weifang Medical University · CNJinan Foundry and Metalforming Machinery Research Institute (China) · CNXian Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNasopharyngeal carcinoma (NPC) is a major head and neck cancer with high occurrence in Southeast Asia and southern China. Insulin receptor substrate

methodsQuantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR) and Western blot were used to analyze the expression of

resultsThis study reports that IRS-1 protein was weakly expressed in NPC specimens, but highly in healthy controls. Serum

conclusionOur data indicates that serum

Indexed as

diagnosisInsulin receptor substrate-1nasopharyngeal carcinoma

Identifiers

PMID31949750

PMCPMC6962894

OpenAlexW3028373446

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.